logo

For the Inventor, By the Inventor

London, United Kingdom

Topivert Pharma Limited

Calculating rank
USPTO Granted Patents = 26

% Expired Patents = 57.7


Forward Citations = 171

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Matthew Colin Thor Fyfe (22 out of 23 patents)

silverMedal Stephen Thom (14 out of 60 patents)

bronzeMedal Thomas Matthew Baker (6 out of 10 patents)

4.  Premji Meghani (6 out of 40 patents)

5.  Stuart Thomas Onions (4 out of 67 patents)

6.  John King-Underwood (4 out of 39 patents)

7.  Gareth Harbottle (3 out of 7 patents)

8.  Aaron Rigby (3 out of 4 patents)

9.  Alistair Ian Longshaw (3 out of 20 patents)

10.  Euan Alexander Fraser Fordyce (3 out of 20 patents)

11.  Geraint Jones (3 out of 7 patents)

12.  Vedran Hasimbegovic (3 out of 3 patents)

13.  Kazuhiro Ito (2 out of 49 patents)

14.  Peter John Murray (2 out of 38 patents)

15.  Catherine Elisabeth Charron (2 out of 21 patents)


Core Competencies:
Kinase Inhibitors
Janus Kinase
Urea Derivatives
Pyrazole Compounds
p38 MAP Kinase
Inhibitors
Tetrahydroimidazoles
Hexahydroimidazoles
N-Alkyl Pyrazoles
Therapeutic Applications
Pharmaceutical Chemistry

26 patents:

1. 10882859 - Kinase inhibitors (2021-01-05),
2. 10851097 - 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as janus kinase inhibitors (2020-12-01),
3. 10556901 - 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as Janus kinase inhibitors (2020-02-11),
4. 10442828 - Kinase inhibitors (2019-10-15),
5. 10435361 - Kinase inhibitors (2019-10-08),
6. 10392346 - Kinase inhibitors (2019-08-27),
7. 10301288 - Kinase inhibitors (2019-05-28),
8. 10125100 - Kinase inhibitors (2018-11-13),
9. 10072034 - Kinase inhibitors (2018-09-11),
10. 9890185 - Urea derivatives useful as kinase inhibitors (2018-02-13),
11. 9850233 - Kinase inhibitors (2017-12-26),
12. 9822076 - Kinase inhibitor (2017-11-21),
13. 9796742 - Kinase inhibitors (2017-10-24),
14. 9790209 - Kinase inhibitors (2017-10-17),
15. 9790174 - Kinase inhibitors (2017-10-17),
Company Overview
Topivert Pharma Limited is a biopharmaceutical company based in London, specializing in the development of innovative therapies for chronic inflammatory conditions. The organization focuses on leveraging advanced drug delivery systems and formulation technologies to enhance patient outcomes. With a commitment to addressing unmet medical needs, Topivert Pharma is dedicated to advancing its research in areas such as dermatology and other inflammatory diseases, aiming to provide effective solutions for patients globally.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

26 Patents

#146 in London

#681 in United Kingdom

#24,848 in the World

London, GB
London, United Kingdom

Topivert Pharma Limited

Forward Citations = 171

27 inventors:

goldMedal Matthew Colin Thor Fyfe (22 out of 23 patents)

silverMedal Stephen Thom (14 out of 60 patents)

bronzeMedal Thomas Matthew Baker (6 out of 10 patents)

4.  Premji Meghani (6 out of 40 patents)

5.  Stuart Thomas Onions (4 out of 67 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Topivert Pharma Limited. Retrieved from https://idiyas.com/company/topivert-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…